<DOC>
	<DOCNO>NCT01456351</DOCNO>
	<brief_summary>The study address question therapy bendamustine plus rituximab comparable ( non inferior ) well-tried combination fludarabine plus rituximab regard event free survival ( EFS ) recurrent low malignant Non-Hodgkin mantle cell lymphoma .</brief_summary>
	<brief_title>Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Patients histological verify CD20positive BCellLymphomas follow entity : Follicular lymphoma grade 1 2 Immunocytoma lymphoplasmocytic lymphoma Marginal zone lymphoma , nodal generalise Mantle cell lymphoma lymphocytic lymphoma ( CLL without leucaemic characteristic ) nonspecified/classified lymphomas low malignancy Recurrent disease ( remission duration minimum 3 month ) , independent type quantity prior therapy , except Rituximab contain regimen , remission duration &gt; 1 year Rituximab contain regimen , refractory prior therapy ( progression therapy 3 month completion ) , except refractory disease purin analog Bendamustine Need therapy , except mantle cell lymphomas Stadium II ( bulky disease , 7.5 cm ) , II IV Written inform consent Performance status WHO 02 Histology old 6 month Patients establish mention prerequisite Option primary , potentially curative radiation therapy Patients refractory Rituximab contain regimen Comorbidities exclude study conform therapy : heart attack last 6 month severe , medicinal adjustable hypertonia severe functional defect heart ( NYHA III IV ) lung ( WHO grade III IV ) liver kidney ( creatinine &gt; 2 mg/dl , GOT + GPT bilirubin 3 x ULN , except cause lymphoma Active auto immunohemolytic anemia ( AIHA ) HIV positive patient Active hepatitis infection Severe psychiatric diseases No compliance noncompliance expect Pregnant breast feed woman Anamnestic malignancy secondary malignancy , proven Cured/curable surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Event free survival</keyword>
	<keyword>Remission rate</keyword>
	<keyword>Toxicity</keyword>
	<keyword>Overall survival</keyword>
	<keyword>Efficiency cost</keyword>
	<keyword>Recurrent low grade</keyword>
</DOC>